- Home
- RLAY vs IFN Comparison
RLAY vs IFN Comparison
Compare RLAY & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- IFN
- Stock Information
- Founded
- RLAY 2015
- IFN 1993
- Country
- RLAY United States
- IFN Singapore
- Employees
- RLAY N/A
- IFN N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- IFN Finance/Investors Services
- Sector
- RLAY Health Care
- IFN Finance
- Exchange
- RLAY Nasdaq
- IFN Nasdaq
- Market Cap
- RLAY 620.4M
- IFN 560.2M
- IPO Year
- RLAY 2020
- IFN N/A
- Fundamental
- Price
- RLAY $2.62
- IFN $15.75
- Analyst Decision
- RLAY Strong Buy
- IFN
- Analyst Count
- RLAY 10
- IFN 0
- Target Price
- RLAY $19.33
- IFN N/A
- AVG Volume (30 Days)
- RLAY 2.5M
- IFN 135.2K
- Earning Date
- RLAY 05-01-2025
- IFN 01-01-0001
- Dividend Yield
- RLAY N/A
- IFN 8.68%
- EPS Growth
- RLAY N/A
- IFN N/A
- EPS
- RLAY N/A
- IFN N/A
- Revenue
- RLAY $10,007,000.00
- IFN N/A
- Revenue This Year
- RLAY N/A
- IFN N/A
- Revenue Next Year
- RLAY $544.28
- IFN N/A
- P/E Ratio
- RLAY N/A
- IFN N/A
- Revenue Growth
- RLAY N/A
- IFN N/A
- 52 Week Low
- RLAY $2.45
- IFN $14.40
- 52 Week High
- RLAY $10.72
- IFN $21.25
- Technical
- Relative Strength Index (RSI)
- RLAY 32.07
- IFN 57.63
- Support Level
- RLAY $3.05
- IFN $14.60
- Resistance Level
- RLAY $3.08
- IFN $15.88
- Average True Range (ATR)
- RLAY 0.25
- IFN 0.20
- MACD
- RLAY -0.04
- IFN 0.09
- Stochastic Oscillator
- RLAY 11.64
- IFN 77.18
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About IFN India Fund Inc. (The)
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing primarily in the equity securities of Indian companies. The company's portfolio is non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities and others. Geographically, all the business activity functions through the market of United States.